Results 71 to 80 of about 9,498 (160)

Clinico-radiological Evaluation in Hepatitis C Patients in a Tertiary Care Hospital: A Cross-sectional Study

Assam Journal of Internal Medicine
Background: Hepatitis C virus (HCV) infection remains a major global health concern and is a leading cause of chronic liver disease, including fibrosis, cirrhosis, and hepatocellular carcinoma.
Jayjayanti Roy, Rima Moni Doley, Anup Kumar Das, Prasanta Dihingia, Aparna Sonowal, Dhruba Borpatragohain   +5 more
doaj   +1 more source

Combination ledipasvir-sofosbuvir for the treatment of chronic hepatitis C virus infection: a review and clinical perspective

Therapeutics and Clinical Risk Management, 2016
Marcel Nkuize,1 Thomas Sersté,1,2 Michel Buset,1 Jean-Pierre Mulkay11Department of Gastroenterology and Hepatology, Saint-Pierre University Hospital, 2Department of Gastroenterology, Pancreatology and Hepatology, Hôpital Academique Erasme ...
Nkuize M, Sersté T, Buset M, Mulkay JP
doaj  

Molnupiravir is effective against hepatitis E virus infection in an animal model. [PDF]

Hepatol Commun
Wu S, Chew NF, Ma X, Situ J, Shun EH, Li C, Ip JD, Ho SS, Zhang AJ, Tsoi JY, Chan WM, Ma W, Liang Y, Mao W, Chen KWY, Yin F, To KK, Yuan S, Chan JF, Zhu L, Huang Y, Sridhar S.   +21 more
europepmc   +1 more source

Real-world Effectiveness and Safety of Coblopasvir plus Sofosbuvir in the Treatment of Chronic Hepatitis C Infection in Wenzhou, Eastern China: A Multicenter Observational Study. [PDF]

J Clin Transl Hepatol
Ruan LM, Zhang XC, Zhang XY, Zhou QQ, Zheng QN, Fu CL, Hu YB, Zhou Y, Wu YH.   +8 more
europepmc   +1 more source

Short-Term Clinical and Immunologic Outcomes Conditional on SVR12 in Hepatitis C Virus-Associated Cryoglobulinemic Vasculitis Treated With Direct-Acting Antivirals: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Boonpheng B, Ungprasert P.
europepmc   +1 more source

Potential Drug Interactions in Psychiatric Patients Undergoing Pangenotypic Therapy for Hepatitis C Virus Infection. [PDF]

Pharmaceuticals (Basel)
Dybowska D, Pawłowska M, Kozielewicz D.
europepmc   +1 more source

Histopathological features and eight-week split-tablet sofosbuvir/velpatasvir treatment in young children with acute hepatitis C: a case-series study. [PDF]

BMC Infect Dis
Pan YJ, Chen RY, Ai YQ, Zeng QL.
europepmc   +1 more source

Mechanism of SARS-CoV-2 resistance to nucleotide analog-based antivirals. [PDF]

Nat Commun
Liu C, Li Y, Cao X, Gleason RJ, Liu B, Yang Y.   +5 more
europepmc   +1 more source

Economic evaluations of Glecaprevir/Pibrentasvir and Grazoprevir/Elbasvir for the treatment of hepatitis C: a systematic review. [PDF]

Cost Eff Resour Alloc
Jafari M, Mehdizadeh P, Teymourzadeh E, Salesi M, Keshavarz K, Abyazi MA, Heiat M, Alavian SM.   +7 more
europepmc   +1 more source

Identification of NS5B resistance-associated mutations in hepatitis C virus circulating in treatment-naïve Cameroonian patients. [PDF]

IJID Reg
Mounchili-Njifon A, Modiyinji AF, Mbouyap PR, Monamele CG, Moumbeket-Yifomnjou MH, Mfombouot PHN, Machuetum GL, Toueyem PI, Lissock SF, Tagnouokam-Ngoupo PA, Assam JPA, Njouom R.   +11 more
europepmc   +1 more source